CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0.0%

Compliant submissions 0

Incompliant submissions 1

Total trials 1

My Organizations' Clinical Trials

Showing 175 of 1294 entries

View as:

Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention

Phase: N/A Priority: Normal

NCT ID: NCT01752504 Org: User:

Start: 11/30/11 End: 05/31/16 Due: 05/31/17

Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO

Phase: N/A Priority: Normal

NCT ID: NCT01460329 Org: User:

Start: 10/31/11 End: 06/30/12 Due: 06/30/13

Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults

Phase: N/A Priority: Normal

NCT ID: NCT00839189 Org: User:

Start: 10/31/02 End: 06/30/06 Due: 06/30/07

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

Phase: N/A Priority: Normal

NCT ID: NCT00407732 Org: User:

Start: 01/31/07 End: 10/31/11 Due: 10/31/12

Self-monitoring and Reflection's Impact on Psychotherapy Outcomes: A Trial Protocol.

Phase: N/A Priority: Normal

NCT ID: NCT06038747 Org: User:

Start: 09/15/23 End: 01/23/24 Due: 01/23/25

Clinical Outcomes Maxilla: Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine

Phase: N/A Priority: Normal

NCT ID: NCT02747186 Org: User:

Start: 05/31/16 End: 12/31/17 Due: 12/31/18

The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

Phase: N/A Priority: Normal

NCT ID: NCT01251601 Org: User:

Start: 11/30/10 End: 09/30/11 Due: 09/30/12

A Study of the Feasibility of Prehospital Remote Ischemic Conditioning

Phase: N/A Priority: Normal

NCT ID: NCT03400579 Org: User:

Start: 07/10/18 End: 10/01/19 Due: 10/01/20

Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi

Phase: N/A Priority: Normal

NCT ID: NCT04286243 Org: User:

Start: 03/04/20 End: 12/18/21 Due: 12/18/22

Promoting Viral Suppression Among Transgender Women Living With HIV in Santo Domingo

Phase: N/A Priority: Normal

NCT ID: NCT06316102 Org: User:

Start: 07/14/23 End: 06/01/25 Due: 06/01/26

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Phase: N/A Priority: Normal

NCT ID: NCT02772965 Org: User:

Start: 10/31/16 End: 04/07/22 Due: 04/07/23

SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF

Phase: N/A Priority: Normal

NCT ID: NCT04415489 Org: User:

Start: 12/06/19 End: 12/01/20 Due: 12/01/21

Wrist Fracture Evaluation With a Desktop Orthopedic Tomosynthesis System

Phase: N/A Priority: Normal

NCT ID: NCT03993691 Org: User:

Start: 11/05/19 End: 11/03/21 Due: 11/03/22

Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers

Phase: N/A Priority: Normal

NCT ID: NCT00224900 Org: User:

Start: 09/30/05 End: 05/31/06 Due: 05/31/07

Collaborate and Leverage Evidence in African American Rural Network

Phase: N/A Priority: Normal

NCT ID: NCT06730633 Org: User:

Start: 02/22/25 End: 05/31/26 Due: 05/31/27

SMILE: Clinical Trial to Evaluate Mindfulness as Intervention for Racial and Ethnic Populations During COVID-19

Phase: N/A Priority: Normal

NCT ID: NCT06242080 Org: User:

Start: 05/13/24 End: 09/01/25 Due: 09/01/26

Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi

Phase: N/A Priority: Normal

NCT ID: NCT06397690 Org: User:

Start: 02/10/25 End: 07/31/25 Due: 07/31/26

Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Phase: N/A Priority: Normal

NCT ID: NCT00799474 Org: User:

Start: 12/31/08 End: 01/31/09 Due: 01/31/10

Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate

Phase: N/A Priority: Normal

NCT ID: NCT01371864 Org: User:

Start: 08/31/11 End: 12/31/11 Due: 12/31/12

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT01731119 Org: User:

Start: 12/31/12 End: 08/31/14 Due: 08/31/15

Treatment for Periodontal Disease in Dialysis Patients

Phase: N/A Priority: Normal

NCT ID: NCT00937976 Org: User:

Start: 08/31/08 End: 06/30/10 Due: 06/30/11

One-session Treatment for Spider Fears

Phase: N/A Priority: Normal

NCT ID: NCT03410264 Org: User:

Start: 01/20/18 End: 04/08/20 Due: 04/08/21

Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity

Phase: N/A Priority: Normal

NCT ID: NCT04291560 Org: User:

Start: 03/01/20 End: 12/20/24 Due: 12/20/25

Empowerment Intervention for Young Women - Phase I

Phase: N/A Priority: Normal

NCT ID: NCT00891358 Org: User:

Start: 11/30/08 End: 04/30/13 Due: 04/30/14

Linkage to Care - Part II

Phase: N/A Priority: Normal

NCT ID: NCT00891644 Org: User:

Start: 06/30/09 End: 07/31/10 Due: 07/31/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention	NCT01752504	University of North Carolina, Chapel Hill	user2@example.com	None	2011-11-30	2016-05-31	2017-05-31	-	-	2025-07-14
Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO	NCT01460329	University of North Carolina, Chapel Hill	user2@example.com	None	2011-10-31	2012-06-30	2013-06-30	-	-	2025-07-14
Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults	NCT00839189	University of North Carolina, Chapel Hill	user2@example.com	None	2002-10-31	2006-06-30	2007-06-30	-	-	2025-07-14
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C	NCT00407732	University of North Carolina, Chapel Hill	user2@example.com	None	2007-01-31	2011-10-31	2012-10-31	-	-	2025-07-14
Self-monitoring and Reflection's Impact on Psychotherapy Outcomes: A Trial Protocol.	NCT06038747	University of North Carolina, Chapel Hill	user2@example.com	None	2023-09-15	2024-01-23	2025-01-23	-	-	2025-07-14
Clinical Outcomes Maxilla: Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine	NCT02747186	University of North Carolina, Chapel Hill	user2@example.com	None	2016-05-31	2017-12-31	2018-12-31	-	-	2025-07-14
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters	NCT01251601	University of North Carolina, Chapel Hill	user2@example.com	None	2010-11-30	2011-09-30	2012-09-30	-	-	2025-07-14
A Study of the Feasibility of Prehospital Remote Ischemic Conditioning	NCT03400579	University of North Carolina, Chapel Hill	user2@example.com	None	2018-07-10	2019-10-01	2020-10-01	-	-	2025-07-14
Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi	NCT04286243	University of North Carolina, Chapel Hill	user2@example.com	None	2020-03-04	2021-12-18	2022-12-18	-	-	2025-07-14
Promoting Viral Suppression Among Transgender Women Living With HIV in Santo Domingo	NCT06316102	University of North Carolina, Chapel Hill	user2@example.com	None	2023-07-14	2025-06-01	2026-06-01	-	-	2025-07-14
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy	NCT02772965	University of North Carolina, Chapel Hill	user2@example.com	None	2016-10-31	2022-04-07	2023-04-07	-	-	2025-07-14
SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF	NCT04415489	University of North Carolina, Chapel Hill	user2@example.com	None	2019-12-06	2020-12-01	2021-12-01	-	-	2025-07-14
Wrist Fracture Evaluation With a Desktop Orthopedic Tomosynthesis System	NCT03993691	University of North Carolina, Chapel Hill	user2@example.com	None	2019-11-05	2021-11-03	2022-11-03	-	-	2025-07-14
Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers	NCT00224900	University of North Carolina, Chapel Hill	user2@example.com	None	2005-09-30	2006-05-31	2007-05-31	-	-	2025-07-14
Collaborate and Leverage Evidence in African American Rural Network	NCT06730633	University of North Carolina, Chapel Hill	user2@example.com	None	2025-02-22	2026-05-31	2027-05-31	-	-	2025-07-14
SMILE: Clinical Trial to Evaluate Mindfulness as Intervention for Racial and Ethnic Populations During COVID-19	NCT06242080	University of North Carolina, Chapel Hill	user2@example.com	None	2024-05-13	2025-09-01	2026-09-01	-	-	2025-07-14
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi	NCT06397690	University of North Carolina, Chapel Hill	user2@example.com	None	2025-02-10	2025-07-31	2026-07-31	-	-	2025-07-14
Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination	NCT00799474	University of North Carolina, Chapel Hill	user2@example.com	None	2008-12-31	2009-01-31	2010-01-31	-	-	2025-07-14
Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate	NCT01371864	University of North Carolina, Chapel Hill	user2@example.com	None	2011-08-31	2011-12-31	2012-12-31	-	-	2025-07-14
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents	NCT01731119	University of North Carolina, Chapel Hill	user2@example.com	None	2012-12-31	2014-08-31	2015-08-31	-	-	2025-07-14
Treatment for Periodontal Disease in Dialysis Patients	NCT00937976	University of North Carolina, Chapel Hill	user2@example.com	None	2008-08-31	2010-06-30	2011-06-30	-	-	2025-07-14
One-session Treatment for Spider Fears	NCT03410264	University of North Carolina, Chapel Hill	user2@example.com	None	2018-01-20	2020-04-08	2021-04-08	-	-	2025-07-14
Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity	NCT04291560	University of North Carolina, Chapel Hill	user2@example.com	None	2020-03-01	2024-12-20	2025-12-20	-	-	2025-07-14
Empowerment Intervention for Young Women - Phase I	NCT00891358	University of North Carolina, Chapel Hill	user2@example.com	None	2008-11-30	2013-04-30	2014-04-30	-	-	2025-07-14
Linkage to Care - Part II	NCT00891644	University of North Carolina, Chapel Hill	user2@example.com	None	2009-06-30	2010-07-31	2011-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance